With a $2 billion valuation, Tilray Brands (NASDAQ:TLRY) ranks as the largest cannabis company outside the U.S., leading in international sales and the Canadian recreational market. Pablo Zuanic of Zuanic & Associates has initiated coverage on Tilray with a 'Neutral' rating, highlighting the company's significant potential in global markets.

"In a bull-case scenario, the stock could be near $7 a year from now. On near-term execution and reinvestment risk, we prefer to start at Neutral but are long-term constructive," Zuanic wrote. "Tilray is focused on building an alcohol drinks ecosystem in the US that it believes...